This guide covers everything Hashimoto's patients need to understand about GLP-1 therapy , from the research on safety and thyroid function to practical monitoring schedules, supplement considerations , medication timing, and the specific scenarios where these medications could genuinely help versus situations where caution is warranted
Clinical studies confirm that chronic treatment with AOD9604 showed no adverse effect on insulin sensitivity, making it a metabolically selective approach to body composition optimization under medical supervision
IGF-1 LR3 falls under the World Anti-Doping Agency's S2 category (peptide hormones, growth factors, related substances, and mimetics) and is prohibited at all times both in and out of competition
Should I choose recovery or growth peptides
For steady, predictable research the 100mg is the efficient call
Apr 22 2025;110(5):e1687-e1696